News
Research Progress
De Novo Mutations of CCNK Cause a Syndromic Neurodevelopmental Disorder with Distinctive Facial Dysmorphism
2018-11-16
Am J Hum Genet.  103(3):448-455 Sep 2018 

Fan, Yanjie; Yin, Wu; Hu, Bing; Kline, Antonie D.; Zhang, Victor Wei; Liang, Desheng; Sun, Yu; Wang, Lili; Tang, Sha; Powis, Zoe; Li, Lei; Yan, Huifang; Shi, Zhen; Yang, Xiaoping; Chen, Yinyin; Wang, Jingmin; Jiang, Yuwu; Tan, Hu; Gu, Xuefan; Wu, Lingqian; Yu, Yongguo

Abstract:

Neurodevelopment is a transcriptionally orchestrated process. Cyclin K, a regulator of transcription encoded by CCNK, is thought to play a critical role in the RNA polymerase II-mediated activities. However, dysfunction of CCNK has not been linked to genetic disorders. In this study, we identified three unrelated individuals harboring de novo heterozygous copy number loss of CCNK in an overlapping 14q32.3 region and one individual harboring a de novo nonsynonymous variant c.331A>G (p.Lys111Glu) in CCNK. These four individuals, though from different ethnic backgrounds, shared a common phenotype of developmental delay and intellectual disability (DD/ID), language defects, and distinctive facial dysmorphism including high hairline, hypertelorism, thin eyebrows, dysmorphic ears, broad nasal bridge and tip, and narrow jaw. Functional assay in zebrafish larvae showed that Ccnk knockdown resulted in defective brain development, small eyes, and curly spinal cord. These defects were partially rescued by wild-type mRNA coding CCNK but not the mRNA with the identified likely pathogenic variant c.331A>G, supporting a causal role of CCNK variants in neurodevelopmental disorders. Taken together, we reported a syndromic neurodevelopmental disorder with DD/ID and facial characteristics caused by CCNK variations, possibly through a mechanism of haploinsufficiency.

https://www.ncbi.nlm.nih.gov/pubmed/30122539


Last updated: Dec. 2018   |  Copyright © Hefei National Laboratory for Physical Sciences at the Microscale  |  Top  |  Site Map